ARTICLE | Top Story
Amgen, Transkaryotic closing arguments
September 8, 2000 7:00 AM UTC
As expected, closing arguments were heard from representatives of AMGN and TKTX in their patent infringement suit related to TKTX's gene activated erythropoietin before Judge William Young of the U.S....